+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare Analytical Testing Services - Global Market Trajectory & Analytics

  • ID: 4804993
  • Report
  • April 2021
  • Region: Global
  • 152 pages
  • Global Industry Analysts, Inc
Global Healthcare Analytical Testing Services Market to Reach $7.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Healthcare Analytical Testing Services estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Method Validation, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Environmental Monitoring segment is readjusted to a revised 10.9% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 9.6% CAGR

The Healthcare Analytical Testing Services market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 9.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 8.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Bioanalytical Services Segment to Record 9.1% CAGR

In the global Bioanalytical Services segment, USA, Canada, Japan, China and Europe will drive the 9.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$876.8 Million in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$833.2 Million by the year 2027.

Select Competitors (Total 46 Featured):
  • Charles River Laboratories International, Inc.
  • Envigo, Inc.
  • Eurofins Scientific SE
  • Exova Group PLC
  • Intertek Group PLC
  • Laboratory Corporation of America Holdings (LabCorp)
  • Merck KgaA
  • MPI Research, Inc.
  • Pace Analytical Services, Inc.
  • Pharmaceutical Product Development LLC
  • SGS SA
  • Source BioScience PLC
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Healthcare Analytical Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Healthcare Analytical Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Method Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Method Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Environmental Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Environmental Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Bioanalytical Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Bioanalytical Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Stability by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Stability by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Microbial Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Microbial Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for CRO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for CRO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • Table 21: USA Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 22: USA 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 23: USA Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 25: Canada Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: Canada 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 27: Canada Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 29: Japan Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: Japan 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 31: Japan Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Japan 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 33: China Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: China 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 35: China Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: China 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 37: Europe Current & Future Analysis for Healthcare Analytical Testing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 38: Europe 7-Year Perspective for Healthcare Analytical Testing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 39: Europe Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: Europe 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 41: Europe Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: Europe 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 43: France Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: France 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 45: France Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: France 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 47: Germany Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Germany 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 49: Germany Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Germany 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 51: Italy Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: Italy 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 53: Italy Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: Italy 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 55: UK Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: UK 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 57: UK Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: UK 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 59: Rest of Europe Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: Rest of Europe 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 61: Rest of Europe Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Rest of Europe 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 63: Asia-Pacific Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Asia-Pacific 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 65: Asia-Pacific Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Asia-Pacific 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
  • Table 67: Rest of World Current & Future Analysis for Healthcare Analytical Testing Services by Type - Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Rest of World 7-Year Perspective for Healthcare Analytical Testing Services by Type - Percentage Breakdown of Value Sales for Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials and Microbial Testing for the Years 2020 & 2027
  • Table 69: Rest of World Current & Future Analysis for Healthcare Analytical Testing Services by End-Use - Pharmaceutical, Medical Device Companies and CRO - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 70: Rest of World 7-Year Perspective for Healthcare Analytical Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Medical Device Companies and CRO for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
Adroll
adroll